Please note: The information displayed on this page might be outdated.
Gamida Cell Ltd: Gamida Cell is a clinical-stage biopharmaceutical company committed to developing novel cell therapies with the potential to cure difficult-to-treat cancers and rare, serious hematologic diseases. We are leveraging our proprietary nicotinamide-based cell expansion technology, or NAM technology, to develop product candidates designed to address the limitations of cell therapies.
Based in...
US - New England
Public, USA
Market Cap
100MM - 500MM
673 Boylston Street
4th Floor
Boston, MA 02116
United States

Company Participants at Class of 2018 Biotech IPO Investor Day

  • Jaren Irene Madden, IR/PR
  • Josh Hamermesh, CBO
  • Julian Adams, PhD, CEO
  • Ronit Simantov, MD, CMO
  • Thomas Klima, CCO

Top 10 Holders of Gamida Cell Ltd.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 14.69 4,947,181 34.04 13F 9/30/20
BVF, Inc. 6.37 2,143,667 14.75 13F 9/30/20
Rock Springs Capital Management LP 5.99 2,016,656 13.87 13F 9/30/20
Driehaus Capital Management LLC 5.61 1,889,091 13.00 13F 9/30/20
Federated Global Investment Management Corp. 5.28 1,777,777 12.23 13F 9/30/20
Brinker Capital, Inc. 2.14 719,372 4.95 Funds 5/31/20
Baker Bros. Advisors LP 1.88 633,324 4.36 13F 9/30/20
Alyeska Investment Group LP 1.14 385,187 2.65 13F 9/30/20
Millennium Management LLC 0.59 198,186 1.36 13F 9/30/20
ARK Investment Management LLC 0.55 186,415 1.28 13F 9/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.